The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522 · cited 3×
“Distribution of change from baseline (letters) [median (quartiles)] 3 wks 2 ( 7, 3) 5 ( 1, 8) 6 wks 1 ( 6, 6) 5 ( 2, 12 9 wks 3 ( 5, 6) 7 ( 2, 10 12 wks 1 ( 6, 5) 5 ( 1, 12 Change from baseline [n (%)] 3 wks 15-letter improvement 1 (6) 1 (5) 10-letter improvement 1 (6) 4 (19) Within 9 letters 16 (89) 16 (76) 10 letter…”
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Early Photocoagulation for Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38011-7 · Cited by 1,259
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.06.052 · Cited by 614
A computerized method of visual acuity testing
Beck, R. W., Moke, P. S., Turpin, A. H., Ferris, F. L., SanGiovanni, J. P., Johnson, C. A., Birch, E. E., Chandler, D. L., Cox, T. A., Blair, R. C., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01825-1 · Cited by 607
Treatment Techniques and Clinical Guidelines for Photocoagulation of Diabetic Macular Edema
(1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33527-4 · Cited by 544
INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA
HARITOGLOU, C., KOOK, D., NEUBAUER, A., WOLF, A., PRIGLINGER, S., STRAUSS, R., GANDORFER, A., ULBIG, M., & KAMPIK, A. (2006) · Retina · doi:10.1097/01.iae.0000247165.38655.bf · Cited by 453
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
Nguyen, Q. D., Tatlipinar, S., Shah, S. M., Haller, J. A., Quinlan, E., Sung, J., Zimmer-Galler, I., Do, D. V., & Campochiaro, P. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.068 · Cited by 351
Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema
Arevalo, J. F., Fromow-Guerra, J., Quiroz-Mercado, H., Sanchez, J. G., Wu, L., Maia, M., Berrocal, M. H., Solis-Vivanco, A., & Farah, M. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.028 · Cited by 335
Chun, D. W., Heier, J. S., Topping, T. M., Duker, J. S., & Bankert, J. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.033 · Cited by 295
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.469 · Cited by 274
Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid
Pendergast, S. D., Hassan, T. S., Williams, G. A., Cox, M. S., Margherio, R. R., Ferrone, P. J., Garretson, B. R., & Trese, M. T. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00472-4 · Cited by 253
The PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
Krzystolik, M. G., Strauber, S. F., Aiello, L. P., Beck, R. W., Berger, B. B., Bressler, N. M., Browning, D. J., Chambers, R. B., Danis, R. P., Davis, M. D., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.055 · Cited by 169
Costa, R. A., Jorge, R., Calucci, D., Cardillo, J. A., Melo, L. A. S., & Scott, I. U. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0433 · Cited by 165
ELECTROPHYSIOLOGIC FINDINGS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
Maturi, R. K., Bleau, L., & Wilson, D. L. (2006) · Retina · doi:10.1097/00006982-200603000-00003 · Cited by 157
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Grover, S., Fishman, G. A., Birch, D. G., Locke, K. G., & ROSNER, B. A. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00253-7 · Cited by 58
Cited by
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,621
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
Schmidt-Erfurth, U., Garcia-Arumi, J., Bandello, F., Berg, K., Chakravarthy, U., Gerendas, B. S., Jonas, J., Larsen, M., Tadayoni, R., & Loewenstein, A. (2017) · Ophthalmologica · doi:10.1159/000458539 · Cited by 703
Metadata
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 114
- Issue
- 10
- Pages
- 1860-1867.e7
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1559170621
- Cited by
- 451
- References
- 26
- FWCI
- 34.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.